A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to Evaluate the response rate of Gemcitabine with TS-1
in Korean patient with advanced but inoperable, metastatic or recurrent pancreatic cancer who
is not receiving anti cancer therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Korea University Anam Hospital
Collaborators:
Konkuk University Hospital Korea University Korea University Guro Hospital Seoul Municipal Boramae Hospital Seoul National University Bundang Hospital Seoul National University Hospital